Enbrel (etanercept) is a brand-name subcutaneous injection prescribed for psoriatic arthritis (PsA) in adults and juvenile PsA in some children. This article covers topics such as side effects ...

Biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) seem to be the most effective treatments for ...

Patients with uveitis had a higher risk for psoriatic arthritis and psoriasis, whereas those with psoriatic arthritis had a higher risk for uveitis.

Psoriatic arthritis was different ... They even help me take my medicine, which is an injection I give myself at home. They like to be in charge of setting up the supplies and counting down ...

Ustekinumab, a monoclonal antibody, is approved for the treatment of psoriasis vulgaris and psoriatic arthritis.

Sandoz announced the European launch of its Pyzchiva (ustekinumab) autoinjector. This is the first ustekinumab biosimilar in ...

New study shows a subset of psoriatic arthritis patients can achieve long-term remission without DMARDs. Learn who benefits ...

On May 22, 2025, the FDA approved Bio-Thera Solutions and Hikma Pharmaceuticals’ ustekinumab biosimilar, STARJEMZA® (ustekinumab-hmny) ...

After the launch of Ustekinumab, a biosimilar of Stelara, in the United States and Europe, Biocon Biologics’ biosimilar drug ...

Metabolic syndrome was independently associated with elevated levels of pain catastrophizing among patients with psoriatic arthritis and may impact disease activity. Metabolic syndrome (MetS) is ...